Altamira Therapeutics Ltd. SEC filings CYTOF

Altamira Therapeutics Ltd. has 518 filings in SEC EDGAR's recent list, going back to Mar 18, 2014. Its latest annual report, Form 20-F, was filed on Apr 30, 2025 for the period ended Dec 31, 2024. The most recent current report (Form 6-K) was filed on Aug 29, 2025. The company's fiscal year ends on December 31.

Form Description Filed Period
20-F Annual report (foreign issuer) Apr 30, 2025 Dec 31, 2024
20-F/A Amended annual report (foreign issuer) Jul 1, 2024 Dec 31, 2023
20-F/A Amended annual report (foreign issuer) Apr 22, 2024 Dec 31, 2023
20-F Annual report (foreign issuer) Apr 10, 2024 Dec 31, 2023
20-F Annual report (foreign issuer) May 16, 2023 Dec 31, 2022
20-F Annual report (foreign issuer) Apr 12, 2022 Dec 31, 2021
20-F Annual report (foreign issuer) Mar 31, 2021 Dec 31, 2020
20-F Annual report (foreign issuer) Apr 16, 2020 Dec 31, 2019
20-F Annual report (foreign issuer) Mar 14, 2019 Dec 31, 2018
20-F Annual report (foreign issuer) Mar 22, 2018 Dec 31, 2017
20-F Annual report (foreign issuer) Mar 14, 2017 Dec 31, 2016
20-F Annual report (foreign issuer) Mar 14, 2016 Dec 31, 2015
20-F Annual report (foreign issuer) Mar 31, 2015 Dec 31, 2014

Showing 13 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CYTOF (OTC)
Fiscal year ends
December 31
Incorporated in
Bermuda
Headquarters
Hamilton Hm 11, Bermuda
SEC filer status
Non-accelerated filer
SEC CIK
1601936
Former names
Auris Medical Holding Ltd. (until Jul 23, 2021); Auris Medical Holding AG (until Mar 14, 2019); Auris Medical AG (until Apr 18, 2014)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.